I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares rose 1.04% to $139.24, outperforming the broader market which saw declines in the S&P 500 and Dow Jones. This marks the stock's second consecutive day of gains. While competitors like DexCom and Johnson & Johnson also rose, Eli Lilly fell slightly. Insulet remains significantly below its 52-week high, and trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) rallied 1.04% to $139.24 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.45% to 7,585.73 and Dow Jones Industrial Average falling 0.63% to 52,093.11.
This was the stock's second consecutive day of gains.
Insulet Corp. closed 60.76% short of its 52-week high of $354.88, which the company achieved on November 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. (LLY) fell 0.19% to $1,136.11, DexCom Inc. (DXCM) rose 2.09% to $86.45, and Johnson & Johnson (JNJ) rose 0.33% to $267.20.
Trading volume (1.4 M) remained 223,215 below its 50-day average volume of 1.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-15-26 1717ET